Healthcare Finance Staff
North Dakota's largest health insurer has made a quick turnaround after a year of underwriting losses and lost technology contracts.
James Colbert, MD, Harvard medical instructor and ACO Learning Network consultant, on the challenges and opportunities of designing high value networks and the data needed to do it.
It used to require hundreds of thousands of patients taking a drug to make it blockbuster. But over the last decade drug companies have figured out that they can get to $1 billion in product sales with much smaller populations. The key: sky-high prices.
Administrative bloat may not be the main cost-driver, but the chronic disease problem won't be controlled until administrators, insurers, Medicare and Medicaid simply get out of the way of primary care physicians.
Women are saving a lot of money as a result of a health law requirement that insurance cover most forms of prescription contraceptives with no additional out-of-pocket costs. But the amount of those savings and the speed with which those savings occurred surprised researchers.
There is little question that healthcare payers, like all healthcare organizations, have mounting challenges when it comes to meeting regulatory compliance standards developed to improve the security, clarity and transparency of healthcare insurance information.
The conversation regarding rising healthcare costs in the U.S. continues to swell with tension and uncertainty. Why do U.S. healthcare costs continue to climb at rates far outpacing other industries?
Trying to bring affordable, painless lab tests to the masses, Theranos is breaking into a new market in collaboration with one of Pennsylvania's major insurers.
Not only are many hospitals getting sizable federal drug discounts, some may be over-prescribing, according to the Government Accountability Office.
The case against Blue Shield of California's tax-exempt status is growing, presenting an additional $40 million to the tax bill, but also the possibility of more drastic state action.